GlassScriptPhysician profile
Andrew H Cohen
NPI 1902845290
$9,470.89
in general payments reported to CMS, 2019-2025
21 companies · $421 in 2025
The $421 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,104 · 2020: $169 · 2021: $363 · 2022: $3,251 · 2023: $1,830 · 2024: $333 · 2025: $421.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,483 · Travel and Lodging: $1,101.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,483.20 |
| Travel and Lodging | $1,101.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| In2bones USA, LLC | $4,992.60 | 2019-2022 | |
| Stryker Corporation | $2,014.04 | 2019-2025 | Infinity, Prophecy, Prostep |
| Linvatec Corporation | $529.20 | 2023 | |
| Paragon 28, INC. | $400.42 | 2019-2025 | Ttc Nail, Mtp, Apex 3d |
| Urgo Medical North America, LLC | $199.88 | 2024-2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Smith+Nephew, INC. | $188.68 | 2019-2025 | Grafix Pl, Collagenase Santyl, Stravix |
| Depuy Synthes Sales INC. | $140.38 | 2021 | |
| Biopro, INC. | $139.14 | 2019-2023 | |
| Zimmer Biomet Holdings, INC. | $111.17 | 2021 | |
| Kerecis Limited | $105.90 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Wright Medical Technology, INC. | $105.65 | 2019-2020 | |
| Solventum Corporation | $103.09 | 2024 | Prevena, V.A.C.Instill, Activ.A.C. |
| Organogenesis INC. | $93.00 | 2019 | |
| Treace Medical Concepts, INC. | $82.60 | 2022-2025 | |
| Cardiovascular Systems INC. | $78.21 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $76.00 | 2020 | |
| Medwest Associates | $49.47 | 2023 | |
| Nevro Corp. | $20.47 | 2024 | Senza |
| Reprise Biomedical, INC. | $16.28 | 2022 | |
| Orpyx Medical Technologies US INC. | $13.08 | 2023 | Orpyx Si |
| Osteomed LLC | $11.63 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Cohen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.